Mills & Reeve's Life Science Law blog has been tracking Brexit developments relevant to the life sciences sector. The blog has analysis of the Government’s no deal Brexit guidance for life sciences businesses as well as on patents and “supplementary protection certificates”. It also has coverage of the MHRA consultation on proposed legislative changes to the regulation of medicines, clinical trials and medical devices in a “no deal” scenario.
You can find a range of other Brexit related resources on Mills & Reeve's Brexit Hub.